Tempus Lens AI platform enterprise access for oncology RWE
Disclosed: Verified: Partners: Tempus AI
Tempus announced an expanded collaboration giving Gilead enterprise-wide access to Tempus's AI-driven Lens platform and multimodal data for oncology R&D and real-world evidence.